Hill Stephen J.
SEC CIK 1866154 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | COO | 16.8K | — | $63.8K | 12 | 2024-02-09 | 2026-08-21 |
Most active insiders at LYEL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ARCH Venture Partners IX Overage, L.P. | 10% | $12.50M | — |
| 2 | BERNS PAUL L | 10% | $12.50M | — |
| 3 | Seely Lynn | Pres, CEO, Dir | — | $353.1K |
| 4 | Bulis Veronica Sanchez | VP, Corp. Ctrl | — | $96.9K |
| 5 | Lee Gary K. | CSO | — | $71.7K |
| 6 | Hill Stephen J. | COO | — | $51.3K |
| 7 | Shook David | Chief Medical Off | — | $31.3K |
| 8 | Innovative Cellular Therapeutics Holdings Ltd | 10% | — | $274.30 |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-25 16:05 | 2026-08-21 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | COO | S - Sale | $15.54 | -989 | 16.8K | -6% | -$15.4K | |
| 2026-08-11 16:18 | 2026-08-10 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | COO | S - Sale | $14.34 | -89 | 17.8K | -0.5% | -$1,276 | |
| 2026-06-15 18:34 | 2026-05-11 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | COO | S - Sale | $18.92 | -89 | 17.9K | -0.5% | -$1,684 | |
| 2026-02-12 | 2026-02-11 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | COO | S - Sale | $23.39 | -1,236 | 17.8K | -6% | -$28.9K | |
| D | 2026-02-11 | 2026-02-09 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | COO | A - Grant | $0.00 | +4,000 | 19.1K | +26% | $0 |
| D | 2026-02-11 | 2026-02-10 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | COO | S - Sale | $23.12 | -109 | 19.0K | -0.6% | -$2,520 |
| 2025-11-12 | 2025-11-10 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | COO | S - Sale | $16.12 | -95 | 15.8K | -0.6% | -$1,531 | |
| 2025-08-22 | 2025-08-21 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | COO | S - Sale | $10.54 | -1,004 | 15.8K | -6% | -$10.6K | |
| 2025-08-22 | 2025-08-20 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | COO | A - Grant | $0.00 | +8,000 | 16.8K | +90% | $0 | |
| M | 2025-08-13 | 2025-08-11+ | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | COO | S - Sale | $10.43 | -185 | 8,849 | -2% | -$1,930 |
| D | 2025-02-26 | 2025-02-10 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | COO | A - Grant | $0.00 | +112.5K | 172.9K | +186% | $0 |
| D | 2024-02-13 | 2024-02-09 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | COO | A - Grant | $0.00 | +40.0K | 48.9K | +448% | $0 |
Purchase Sale Sale after option exercise All abbreviations